Exchanges

Investors anticipating COVID-19 vaccine

Summary

A COVID-19 Vaccine and the Stock Market: Which Industries Could Benefit? Description video: When Pfizer and BioNTech announced the successful test of their COVID-19 vaccine, the overall market rallied in relief. Let’s take a closer look at which industries participated […]

A COVID-19 Vaccine and the Stock Market: Which Industries Could Benefit?

Description video:
When Pfizer and BioNTech announced the successful test of their COVID-19 vaccine, the overall market rallied in relief. Let’s take a closer look at which industries participated in the rally and why. What clues did these groups give about market rotation as the economy continues to recover from the pandemic? \n\nSubscribe: http://bit.ly/SubscribeTDAmeritrade \n\nCheck out Investor Insights for daily livestreamed webcasts with TD Ameritrade education coaches: http://bit.ly/SubscribeTDAmeritradeInvestorInsights\n\nTD Ameritrade is where smart investors get smarter. We post educational videos that bring investing and finance topics back down to earth weekly. Have a question or topic suggestion? Let us know. \nConnect with TD Ameritrade:\nFacebook: http://bit.ly/TDAmeritradeFacebook \nTwitter: http://bit.ly/TwitterTDAmeritrade \nOpen an account with TD Ameritrade: http://bit.ly/SignUpTDAmeritrade

Investors anticipating COVID-19 vaccine

Investors awaiting the release of the COVID-19 vaccine are starting to buy up shares in banks and industrial companies in anticipation of a surge in consumer confidence. However, many market participants remain fearful of risks in sectors devastated by the pandemic..

The emergence of any preventative drug is seen as the best chance to stop the coronavirus, which has killed 1.2 million people, and is a major concern for financial managers awaiting the next major market shift..

As the hype around the U.S. election subsides, investors brace for some good news about vaccines they think is just a matter of time..

«This will change a lot. When we get the vaccine, all pent-up demand will spill out.», – said Stuart Oakley, Head of Cash Trading at Nomura in London. 

Of the approximately 45 vaccines in human trials, Pfizer projects, AstraZeneca and Moderna viewed as the most promising for regulatory approval this year.

Binai Chandgotia, a Hong Kong portfolio manager at Principal Global Investors noted that banks would benefit from increased economic activity and would be helped if bond yields rose. He also advises paying attention to the securities of small companies on the Hong Kong and Singapore exchanges if trade and tourism begin to gain momentum..

Brian Jacobsen, senior investment strategist at Wells Fargo Asset Management in Wisconsin, said industry offers a wide range of opportunities to rebuild confidence in areas such as construction and aviation.

Deutsche Bank operates «vaccine basket» of Singapore dollars and Thai baht, which are believed to benefit from increased trade and tourism, versus the Philippine peso, which is weighted by increased imports.

Industrial enterprises rallied with the broader market this month but lagged well behind global stocks gaining around 5% this year. Baht has also recently risen against the peso.

Investors anticipating COVID-19 vaccine